SCHEMBL996697

SCHEMBL996697

CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCN

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 9/20 1.00
TSHR P16473 3/20 1.00
MEN1 O00255 1/20 1.00
KMT2A Q03164 1/20 1.00
ALDH1A1 P00352 1/20 1.00
EPHX1 P07099 1/20 1.00
CA12 O43570 2/20 0.61
CA1 P00915 2/20 0.61
CA2 P00918 2/20 0.61
CA3 P07451 2/20 0.61
CA4 P22748 2/20 0.61
CA6 P23280 2/20 0.61
CA5A P35218 2/20 0.61
CA7 P43166 2/20 0.61
CA9 Q16790 2/20 0.61
CA14 Q9ULX7 2/20 0.61
CA5B Q9Y2D0 2/20 0.61
THRB P10828 1/20 0.61
LMNA P02545 1/20 0.61
BLM P54132 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8743141 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
Octadecylamine SCHEMBL8339913 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
Hexadecylamine SCHEMBL8466884 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
Icosylamine SCHEMBL11365935 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL23270895 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
Octadecylamine SCHEMBL569813 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL23850566 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
Octadecylamine SCHEMBL3889753 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
Decylamine SCHEMBL21629473 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1
SCHEMBL993821 1.00 DNM1 (1.00) DNM1TSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514517-B2 Anti-blocking compositions comprising interpolymers of ethylene/α-olefins DOW GLOBAL TECHNOLOGIES INC. (US) 2009-04-07 US claimed
EP-1858941-A2 ANTI-BLOCKING COMPOSITIONS COMPRISING INTERPOLYMERS OF ETHYLENE/ALPHA-OLEFINS Dow Global Technologies Inc. (US) 2007-11-28 EP claimed
WO-2006101915-A2 ANTI-BLOCKING COMPOSITIONS COMPRISING INTERPOLYMERS OF ETHYLENE/ALPHA-OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2006-09-28 WO claimed
US-20060199884-A1 Anti-blocking compositions comprising interpolymers of ethylene/alpha-olefins DOW GLOBAL TECHNOLOGIES INC. (US) 2006-09-07 US claimed
US-12509552-B2 Lipidated poly(amino acid) nanostructures THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2025-12-30 US disclosed
US-20220356303-A1 LIPIDATED POLY(AMINO ACID) NANOSTRUCTURES THE CURATORS OF THE UNIVERSITY OF MISSOURI 2022-11-10 US disclosed
US-10766774-B2 Oxidized graphite derivative and method for producing same NIPPON SHOKUBAI CO., LTD. (JP) 2020-09-08 US disclosed
EP-1877513-B1 CAP LINERS, CLOSURES AND GASKETS FROM MULTI-BLOCK POLYMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2019-05-08 EP disclosed
US-20180327269-A1 OXIDIZED GRAPHITE DERIVATIVE AND METHOD FOR PRODUCING SAME NIPPON SHOKUBAI CO., LTD. (JP) 2018-11-15 US disclosed
EP-3375756-A1 OXIDIZED GRAPHITE DERIVATIVE AND METHOD FOR PRODUCING SAME Nippon Shokubai Co., Ltd. (JP) 2018-09-19 EP disclosed
WO-2018050484-A1 LUBRICANT COMPOSITIONS CONTAINING DIUREA COMPOUNDS BASF SE (DE) 2018-03-22 WO disclosed
EP-3293246-A1 LUBRICANT COMPOSITIONS CONTAINING DIUREA COMPOUNDS BASF SE (DE) 2018-03-14 EP disclosed
EP-1858941-A2 ANTI-BLOCKING COMPOSITIONS COMPRISING INTERPOLYMERS OF ETHYLENE/ALPHA-OLEFINS Dow Global Technologies Inc. (US) 2007-11-28 EP disclosed
US-20070112127-A1 Random block copolymers comprising hard block and soft blocks e.g. ethylene-octene multiblock copolymer blended with an oil such as aromatic oil, napththenic oil, paraffinic oil; flexible molded articles; blends have low modulus, while maintaining heat resistance, no surface stickiness DOW GLOBAL TECHNOLOGIES INC. (US) 2007-05-17 US disclosed
WO-2006113000-A2 CAP LINERS, CLOSURES AND GASKETS FROM MULTI-BLOCK POLYMERS DOW GLOBAL TECHNOLOGIES INC. (US) 2006-10-26 WO disclosed
WO-2006101915-A2 ANTI-BLOCKING COMPOSITIONS COMPRISING INTERPOLYMERS OF ETHYLENE/ALPHA-OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2006-09-28 WO disclosed
WO-2006102154-A2 POLYMER BLENDS FROM INTERPOLYMERS OF ETHYLENE/ALPHA-OLEFINS AND FLEXIBLE MOLDED ARTICLES MADE THEREFROM DOW GLOBAL TECHNOLOGIES, INC. (US) 2006-09-28 WO disclosed
US-20060211819-A1 Polymer blends from interpolymers of ethylene/alpha-olefins and flexible molded articles made therefrom DOW GLOBAL TECHNOLOGIES INC. (US) 2006-09-21 US disclosed
US-20060199911-A1 Cap liners, closures and gaskets from multi-block polymers DOW GLOBAL TECHNOLOGIES INC. (US) 2006-09-07 US disclosed
US-20060199884-A1 Anti-blocking compositions comprising interpolymers of ethylene/alpha-olefins DOW GLOBAL TECHNOLOGIES INC. (US) 2006-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112127-A1 Random block copolymers comprising hard block and soft blocks e.g. ethylene-octene multiblock copolymer blended with an oil such as aromatic oil, napththenic oil, paraffinic oil; flexible molded articles; blends have low modulus, while maintaining heat resistance, no surface stickiness ALOX12, ALOX15, LTB4R2 DNM1 4423/4885TSHR 4029/4885MEN1 1609/4885
US-12509552-B2 Lipidated poly(amino acid) nanostructures LNPEP, SET, PLTP DNM1 2209/4885TSHR 3321/4885MEN1 1933/4885
US-20220356303-A1 LIPIDATED POLY(AMINO ACID) NANOSTRUCTURES LNPEP, NPEPPS, PHOSPHO1 DNM1 1868/4885TSHR 4138/4885MEN1 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.